Literature DB >> 22511208

The management of overactive bladder syndrome.

Serge P Marinkovic1, Eric S Rovner, Robert M Moldwin, Stuart L Stanton, Lisa M Gillen, Christina M Marinkovic.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22511208     DOI: 10.1136/bmj.e2365

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  14 in total

1.  Publicly funded overactive bladder drug treatment patterns in Ontario over 15 years: An ecological study.

Authors:  Mina Tadrous; Dean Elterman; Wayne Khuu; Muhammad M Mamdani; David N Juurlink; Tara Gomes
Journal:  Can Urol Assoc J       Date:  2017-12-22       Impact factor: 1.862

Review 2.  Efficacy and safety of imidafenacin for overactive bladder in adult: a systematic review and meta-analysis.

Authors:  Wei Huang; Huantao Zong; Xin Zhou; Yong Zhang
Journal:  Int Urol Nephrol       Date:  2015-01-31       Impact factor: 2.370

3.  Anticholinergic medication use for female overactive bladder in the ambulatory setting in the United States.

Authors:  Rujin Ju; Joanne Garrett; Jennifer M Wu
Journal:  Int Urogynecol J       Date:  2013-10-25       Impact factor: 2.894

Review 4.  Mirabegron: a Beta-3 agonist for overactive bladder.

Authors:  Rebecca Bragg; Danielle Hebel; Scott Martin Vouri; Jamie M Pitlick
Journal:  Consult Pharm       Date:  2014-12

5.  Antimuscarinic Medication Use in Elderly Patients with Overactive Bladder.

Authors:  Nandita Kachru; Sneha Sura; Satabdi Chatterjee; Rajender R Aparasu
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

Review 6.  Overactive Bladder Syndrome: Evaluation and Management.

Authors:  Elad Leron; Adi Y Weintraub; Salvatore A Mastrolia; Polina Schwarzman
Journal:  Curr Urol       Date:  2018-02-20

7.  Antimuscarinic use among older adults with dementia and overactive bladder: a Medicare beneficiaries study.

Authors:  Nandita Kachru; Holly M Holmes; Michael L Johnson; Hua Chen; Rajender R Aparasu
Journal:  Curr Med Res Opin       Date:  2021-05-13       Impact factor: 2.705

Review 8.  Refractory overactive bladder: a common problem?

Authors:  Ulrich Schwantes; Joachim Grosse; Andreas Wiedemann
Journal:  Int Urogynecol J       Date:  2015-03-20       Impact factor: 2.894

9.  Long-term safety, efficacy, and tolerability of imidafenacin in the treatment of overactive bladder: a review of the Japanese literature.

Authors:  Naoya Masumori
Journal:  Patient Prefer Adherence       Date:  2013-01-30       Impact factor: 2.711

10.  Testing and Treating Women after Unsuccessful Conservative Treatments for Overactive Bladder or Mixed Urinary Incontinence: A Model-Based Economic Evaluation Based on the BUS Study.

Authors:  Ilias Goranitis; Pelham Barton; Lee J Middleton; Jonathan J Deeks; Jane P Daniels; Pallavi Latthe; Arri Coomarasamy; Suneetha Rachaneni; Shanteela McCooty; Tina S Verghese; Tracy E Roberts
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.